Braves Sign Danny Young to Bolster Bullpen

The Atlanta Braves just made a calculated gamble on upside and familiarity, signing left-handed reliever Danny Young to a one-year major league deal. They’re not just patching a bullpen hole; this is a strategic play to secure a controllable, high-strikeout lefty who already knows the organization and its pitching setup.

Braves Bet on Danny Young’s Upside and Health

The contract looks like a front office hedge: modest short-term cost, but with some real long-term upside. Young’s deal is a one-year major league pact with a split salary structure, so he’ll earn $925,000 in the majors and immediately lands on the Braves’ 40-man roster.

Atlanta isn’t expecting 200 innings or a high-leverage closer here. They’re banking on a recovering lefty with strong underlying numbers who might return to form and deepen a bullpen that’s already built to contend.

Split Contract, But Major League Commitment

The split-salary terms give the Braves some financial wiggle room, but adding Young to the 40-man roster shows they’re serious. This isn’t just a lottery ticket on a non-roster invite.

Once spring training rolls around, Young is expected to move to the 60-day injured list as he continues rehabbing, which opens a spot in the meantime.

A Familiar Face Returns to Atlanta’s Bullpen Mix

This is Young’s second time in Atlanta, and the Braves know what they’re getting—at least when he’s healthy. In 2023, he gave the club a glimpse of his ceiling before injuries cut things short.

Over a small but impressive sample, Young delivered effective innings and flashed the kind of swing-and-miss stuff modern bullpens crave.

Strong 2023 Showing in Limited Action

In 2023, Young tossed 8 1/3 strong innings for the Braves, showing he could miss bats and keep traffic under control. That’s not a huge workload, but it was enough to stick in the minds of Atlanta’s decision-makers.

The Braves circling back to him after surgery says a lot about how they see his potential role down the line.

Tommy John Surgery, Rehab Timeline, and 2026 Outlook

The risk here is obvious: Young is coming back from Tommy John surgery, which he had in May 2025. Recovery usually takes 12–18 months, so the Braves are managing expectations.

Young has already hit an important checkpoint and recently started throwing again as he ramps up toward game action.

Targeting a Midseason Return

The lefty aims to return to the majors before the 2026 All-Star break. Until then, he’ll start the season on the injured list, giving Atlanta the luxury of patience as he rehabs.

If his recovery stays on track, the Braves could “add” a fresh, strikeout-capable lefty arm to their bullpen midseason—the kind of boost contenders really want.

Underlying Metrics Suggest More Than a 4.01 ERA

What really makes Young intriguing isn’t just that he’s left-handed and controllable; it’s how his peripheral numbers outshine his surface ERA. With the Mets over the past two seasons, he pitched effectively out of the bullpen before surgery, and his metrics hint at untapped value.

While the box score says 4.01 ERA, the advanced stats tell a more optimistic story.

Strikeouts and SIERA Point to Hidden Value

Young posted a strong 29% strikeout rate, which you usually see from late-inning relievers, not fringe arms. Pair that with a 3.02 SIERA (Skill-Interactive ERA), and you get the profile of a pitcher who’s been better than his traditional numbers show.

For a team like Atlanta, which leans hard on data-driven decisions, that mix of swing-and-miss stuff and promising underlying numbers is exactly the kind of risk worth taking—even with the injury factor.

Reuniting with Jeremy Hefner and Fitting into the Bullpen Hierarchy

There’s a strong continuity angle here. By coming to Atlanta, Young reunites with pitching coach Jeremy Hefner, who worked with him in New York before making the same move to the Braves.

That continuity in coaching, terminology, and game-planning could help a rehabbing pitcher get back on track faster.

Left-Handed Depth Behind Lee and Bummer

If he’s healthy, Young slots in behind Dylan Lee and Aaron Bummer as another left-handed option. That gives manager Brian Snitker more flexibility with matchups and managing workloads.

Young doesn’t need to be a shutdown closer. If he fills a middle-innings role, misses bats, and keeps his walks down, he’ll make a real impact in the Braves’ bullpen.

Long-Term Control Through 2030 Adds Strategic Value

Maybe the most fascinating part of this signing is the extended team control. Young’s got just over a year of major league service time, so the Braves have him under control through the 2030 season.

From Atlanta’s perspective, this isn’t just a one-year rehab flyer. It’s a potential multi-year asset grab at minimal upfront cost.

A Low-Cost, Long-Horizon Play

If Young gets back to full health and keeps piling up strikeouts, the Braves might have a bargain lefty reliever under control for years. These days, bullpen arms with big upside get pricey in a hurry.

Moves like this can help a club hang onto that competitive edge. Atlanta’s betting on a recovering arm with promising numbers, trusting their coaches, and hoping it all adds up to a steady lefty out of the pen for a while.

 
Here is the source article for this story: Braves Sign Danny Young